DR. ROBERT HAERR, MD

TERRE HAUTE, IN

Research Active
Radiology - Radiation Oncology NPI registered 21+ years 2 publications 1985 – 1991 NPI: 1306849872
Radiology - Radiation Oncology
Head and Neck NeoplasmsAntineoplastic Combined Chemotherapy ProtocolsAcute DiseaseNeoplasm Recurrence, LocalSurvival RateCombined Modality TherapyVincristinePrednisoneIntraoperative CareLymphatic IrradiationLeukemia, Myeloid

Practice Location

1606 N 7TH ST
TERRE HAUTE, IN 47804-2706

Phone: (812) 238-7504

What does ROBERT HAERR research?

Dr. Haerr studies the effects of intraoperative radiation therapy (IORT) in combination with surgery for patients battling recurring head and neck cancer. This type of cancer often presents a challenge, especially when initial treatment options have been exhausted. His research aims to find effective ways to not only control the cancer but also improve the length and quality of life for these patients.

Key findings

  • In a study of 47 patients undergoing IORT, 55% survived for at least two years after treatment.
  • Of the patients treated, 15 lived without cancer for an average of 29 months.
  • The combination of surgery and IORT shows particular promise in controlling disease with microscopic residual cancer.

Frequently asked questions

Does Dr. Haerr study head and neck cancer?
Yes, Dr. Haerr focuses on recurrent head and neck cancer and explores innovative treatment methods.
What treatments has Dr. Haerr researched?
He has researched the use of intraoperative radiation therapy combined with surgery to improve survival outcomes.
Is Dr. Haerr's work relevant to patients with recurrent cancer?
Absolutely, his work specifically addresses the challenges faced by patients with recurrent head and neck cancer.

Publications in plain English

Intraoperative radiation therapy for recurrent head and neck cancer.

1991

Cancer

Rate WR, Garrett P, Hamaker R, Singer M, Pugh N +3 more

Plain English
Researchers studied 47 patients with recurring head and neck cancer who had previously undergone radiation treatment. They found that after combining surgery with a specialized treatment called intraoperative radiation therapy (IORT), about 55% of patients survived for two years, with 15 patients living without any cancer for an average of 29 months. This approach shows promise for controlling the disease and improving survival rates, especially for cases with microscopic remaining cancer. Who this helps: This helps patients with recurrent head and neck cancer.

PubMed

Treatment of chronic myelomonocytic leukemia. Vincristine and prednisone therapy during symptomatic phase or after transformation to acute leukemia.

1985

The Western journal of medicine

Taetle R, Haerr R

PubMed

Frequent Co-Authors

W R Rate P Garrett R Hamaker M Singer N Pugh D Ross G Charles R Taetle

Physician data sourced from the NPPES NPI Registry . Publication data from PubMed . Plain-English summaries generated by AI. Not medical advice.